Biopharmas raising money in public or private financings, including: ADC Therapeutics, Axcella, Ayala, Calliditas, Cardiff Oncology, Cardiol, Citius, Hemogenyx, Kiniksa, Legend Biotech, Modulus Discovery, Myokardia, Oyster Point, Syndax, VBL.

New hires and promotions in the biopharma industry, including: Aruvant, Evox.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Critical Alert, Eko, Novocure, Optina Diagnostics, Zai Lab.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Access Scientific, Apiject, Atrium Health, Butterfly Network, Canon Medical, Carmat, Centene, Change Healthcare, Dermalog, DNA Electronics, The DNA Company, Drӓgerwerk, Edap Tms, Exact Imaging, Liva Healthcare, My Next Health, My Pain Sensei, Nuvo Group, Polyganics, Rapid USA, REMsleep Holdings, Smiths Medical, Surfacide, Thermo Fisher Scientific, United Healthcare Services, Wuxi Diagnostics, Xleratehealth.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Quanterix.

Med-tech firms raising money in public or private financings, including: Cantel Medical, Insulet.

New hires and promotions in the med-tech industry, including: Inolife Sciences.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Arbor, Ascletis, Bluebird, BMS, Cytodyn, Dcprime, Ferring, Novocure, Rhythm, Sunovion, Zai Lab.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aerpio, Beam, Boehringer Ingelheim, CDR-Life, Cipla, Citius, Cmab, Creoptix, Cytoagents, GB004, Forward Pharma, Genespire, Genocea, Gilead, Gossamer, Hetero Labs, Jaguar, Legend, Lipocine, Mind Medicine, Mylan, Noile-Immune, Novellus, Opiant, Oxford Biomedica, Passage Bio, Point Biopharma, Primary Peptides, Qurebio, Reithera, Simcere, Stoke.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actelion, Alexion, Avrobio, Biogen, Capricor, Curis, Fulcrum, Gossamer, I-Mab, Medday, Novadip, Novartis, Novo, Opiant, Roivant.